Changmao Biochemical Engineering Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Chun Pan

Directeur général

CN¥699.0k

Rémunération totale

Pourcentage du salaire du PDG	79.1%
Durée du mandat du directeur général	no data
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	pas de données
Durée moyenne du mandat des membres du conseil d'administration	2.4yrs

Mises à jour récentes de la gestion

Recent updates

Further Upside For Changmao Biochemical Engineering Company Limited (HKG:954) Shares Could Introduce Price Risks After 25% Bounce

Sep 23

Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist

Aug 02

Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled

Nov 18

We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability

Apr 28

Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns

Aug 03

Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital

May 04

Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield

Feb 23

Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?

Jan 26

A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary

Dec 02

Analyse de la rémunération des PDG

Comment la rémunération de Chun Pan a-t-elle évolué par rapport aux bénéfices de Changmao Biochemical Engineering?
Date	Rémunération totale	Salaire	Bénéfices de l'entreprise
Jun 30 2024	n/a	n/a	-CN¥109m
Mar 31 2024	n/a	n/a	-CN¥98m
Dec 31 2023	CN¥699k	CN¥553k	-CN¥86m
Sep 30 2023	n/a	n/a	-CN¥21m
Jun 30 2023	n/a	n/a	CN¥45m
Mar 31 2023	n/a	n/a	CN¥63m
Dec 31 2022	CN¥2m	CN¥545k	CN¥81m
Sep 30 2022	n/a	n/a	CN¥90m
Jun 30 2022	n/a	n/a	CN¥99m
Mar 31 2022	n/a	n/a	CN¥79m
Dec 31 2021	CN¥701k	CN¥563k	CN¥58m
Sep 30 2021	n/a	n/a	CN¥30m
Jun 30 2021	n/a	n/a	CN¥2m
Mar 31 2021	n/a	n/a	CN¥9m
Dec 31 2020	CN¥641k	CN¥538k	CN¥17m
Sep 30 2020	n/a	n/a	CN¥24m
Jun 30 2020	n/a	n/a	CN¥31m
Mar 31 2020	n/a	n/a	CN¥45m
Dec 31 2019	CN¥1m	CN¥745k	CN¥58m
Sep 30 2019	n/a	n/a	CN¥69m
Jun 30 2019	n/a	n/a	CN¥79m
Mar 31 2019	n/a	n/a	CN¥65m
Dec 31 2018	CN¥889k	CN¥545k	CN¥51m
Sep 30 2018	n/a	n/a	CN¥34m
Jun 30 2018	n/a	n/a	CN¥17m
Mar 31 2018	n/a	n/a	CN¥10m
Dec 31 2017	CN¥683k	CN¥543k	CN¥3m

Rémunération vs marché: La rémunération totale de Chun ($USD 96.56K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 233.13K ).

Rémunération et revenus: La rémunération de Chun a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Chun Pan (54 yo)

no data

Titularisation

CN¥699,000

Compensation

Mr. Chun Pan has been General Manager of Changmao Biochemical Engineering Company Limited since April 1, 2014 and also serves as its Chief Executive Officer. He joined Changmao Biochemical in August 1993....

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Xin Sheng Rui	Chairman & Compliance Officer	no data	CN¥800.00k	2.3% HK$ 5.6m
Chun Pan	CEO, GM & Executive Director	no data	CN¥699.00k	pas de données
Jun Peng Zhang	Chief Officer & Employee Representative Supervisor	11.6yrs	CN¥104.00k	pas de données
Yi Xin Leng	Non-Executive Director	no data	CN¥60.00k	0.0098% HK$ 23.9k
Xiao Ping Yu	Non-Executive Director	no data	CN¥60.00k	13.17% HK$ 32.1m
Xian Biao Zeng	Non-Executive Director	no data	CN¥60.00k	pas de données
Rui Juan Zhou	Chairman of the Supervisory Board	no data	CN¥56.00k	pas de données
Jian Ping Wang	Non-Executive Director	17.4yrs	CN¥60.00k	pas de données
Zhi Wei Zhou	Independent Non-Executive Director	2.4yrs	CN¥80.00k	pas de données
Li Qin Rui	Supervisor	2.4yrs	pas de données	pas de données
Rong Xin Shu	Independent Non-Executive Director	2.4yrs	CN¥80.00k	pas de données
Mun Wah Cheng	Independent Non-Executive Director	2.3yrs	CN¥80.00k	pas de données

2.4yrs

Durée moyenne de l'emploi

64.5yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la 954 n'est pas considéré comme expérimenté ( 2.4 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.

Changmao Biochemical Engineering Gestion

Gestion contrôle des critères 2/4

Informations clés

Mises à jour récentes de la gestion

Non-Executive Director recently bought HK$141k worth of stock

Chairman & Compliance Officer recently bought HK$132k worth of stock

Chairman & Compliance Officer recently bought HK$836k worth of stock

Chairman & Compliance Officer recently bought HK$164k worth of stock

Changmao Biochemical Engineering Company Limited, Annual General Meeting, May 28, 2024

Chairman & Compliance Officer recently bought HK$59k worth of stock

Recent updates

Non-Executive Director recently bought HK$141k worth of stock

Further Upside For Changmao Biochemical Engineering Company Limited (HKG:954) Shares Could Introduce Price Risks After 25% Bounce

First half 2024 earnings released: CN¥0.035 loss per share (vs CN¥0.008 profit in 1H 2023)

Changmao Biochemical Engineering Company Limited to Report First Half, 2024 Results on Aug 16, 2024

Chairman & Compliance Officer recently bought HK$132k worth of stock

Chairman & Compliance Officer recently bought HK$836k worth of stock

Chairman & Compliance Officer recently bought HK$164k worth of stock

Changmao Biochemical Engineering Company Limited, Annual General Meeting, May 28, 2024

Full year 2023 earnings released: CN¥0.16 loss per share (vs CN¥0.15 profit in FY 2022)

New minor risk - Financial data availability

Changmao Biochemical Engineering Company Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Chairman & Compliance Officer recently bought HK$59k worth of stock

Chairman & Compliance Officer recently bought HK$231k worth of stock

Chairman & Compliance Officer recently bought HK$54k worth of stock

Chairman & Compliance Officer recently bought HK$327k worth of stock

Chairman & Compliance Officer recently bought HK$277k worth of stock

New major risk - Financial position

First half 2023 earnings released: EPS: CN¥0.008 (vs CN¥0.077 in 1H 2022)

Changmao Biochemical Engineering Company Limited to Report First Half, 2023 Results on Aug 18, 2023

Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist

Now 21% undervalued after recent price drop

Now 22% undervalued after recent price drop

Changmao Biochemical Engineering Company Limited approves Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023

Upcoming dividend of CN¥0.077 per share at 8.4% yield

Full year 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.11 in FY 2021)

Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.077 (vs CN¥0 in 1H 2021)

Changmao Biochemical Engineering Company Limited Announces Appointment of Ms. Cheng Mun Wah as Independent Non-Executive Director and Chairman of Audit Committee, and Member of Remuneration Committee and Nomination Committee

First half 2022 earnings released: EPS: CN¥0 (vs CN¥0 in 1H 2021)

Changmao Biochemical Engineering Company Limited to Report First Half, 2022 Results on Aug 18, 2022

Changmao Biochemical Engineering Company Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Changmao Biochemical Engineering Company Limited Appoints Cheng Mun Wah as Independent Non-Executive Director and Chairman of Audit Committee and Member of Remuneration Committee and Nomination Committee

Changmao Biochemical Engineering Company Limited Approves Board Resignations, Effective 18 June 2022

We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability

Less than half of directors are independent

Changmao Biochemical Engineering Company Limited Omits Final Dividend for the Year Ended 31 December 2021

Full year 2021 earnings released

Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns

Upcoming dividend of CN¥0.02 per share

Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital

Full year 2020 earnings released: EPS CN¥0.032 (vs CN¥0.11 in FY 2019)

Full year 2020 earnings released

Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year Ended 31 December 2020

Changmao Biochemical Engineering Company Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield

Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?

New 90-day high: HK$0.65

A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary

New 90-day low: HK$0.56

First half earnings released

New 90-day low - HK$0.59